Credit: ACS Pharmacology & Translational Science (2024). DOI: 10.1021/acsptsci.3c00360 Oregon State University researchers have discovered compounds that convert a protein known for protecting cancer cells into a tumor killer. Scientists say their findings, several years in the making, open the door to promising therapies for breast cancer and other malignancies whose cells rely on the Bcl-2 protein to evade treatment and develop drug resistance. “The holy grail in cancer research is finding a molecular target that plays a major, essential role in cancer cell growth that you can go after Read More